Last reviewed · How we verify
Pyruvate kinase (PK) deficiency
Approved treatments
- Pyrukynd · Agios Pharms Inc
Pyrukynd works by activating the pyruvate kinase PKLR enzyme to improve energy production in red blood cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pyruvate kinase (PK) deficiency patent landscape — cliff calendar, originator estates, attackable patents
- Pyruvate kinase (PK) deficiency treatment landscape brief
- Pyruvate kinase (PK) deficiency treatment updates RSS
Frequently asked questions about Pyruvate kinase (PK) deficiency
What drugs treat Pyruvate kinase (PK) deficiency?
Tracked treatments include Pyrukynd.
What is the treatment for Pyruvate kinase (PK) deficiency?
Standard treatment for Pyruvate kinase (PK) deficiency includes Pyrukynd. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pyruvate kinase (PK) deficiency patent cliff · Pyruvate kinase (PK) deficiency CI report
- Treatment: Pyrukynd · Agios Pharms Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing